生物技术商业化的战略挑战

Strategic Challenges in Commercializing Biotechnology

CALIFORNIA MANAGEMENT REVIEW · 1990
被引 46
人大 A-ABS 3

中文导读

分析了生物技术公司面临的内部战略挑战,如保持技术卓越、管理商业焦点、形成战略联盟等,并指出外部威胁可能影响行业生存,强调管理者需与公众和政府沟通全球竞争现实。

Abstract

The internal strategic challenges facing biotechnology companies are formidable: maintaining technical excellence in a rapidly advancing scientific field; managing an appropriate commercial focus; forming strategic alliances; adding downstream skills in a timely fashion; and sustaining an innovative corporate culture in the face of accelerating growth. Despite small size, limited resources, and competitive pressures, the biotechnology companies—especially the top-tier companies—are navigating these strategic shoals rather well. However, this industry now faces a series of external threats which might sink it. The outcome will depend on the ability of biotechnology managers to communicate with the public and their representatives in Washington regarding the realities of global competition and the relationship of industrial productivity to the quality of life.

生物技术战略管理商业竞争产业组织